The global Breast Cancer Core Needle Biopsy Market was valued at USD 809.40 million in 2023 and is projected to reach USD 1357.70 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.32% during the forecast period of 2024 to 2032. This remarkable growth is attributed to the rising incidence of breast cancer, increased awareness regarding early cancer detection, and the growing preference for minimally invasive diagnostic techniques.
Core needle biopsy (CNB) has become a standard diagnostic approach in breast cancer detection owing to its high accuracy, reduced patient discomfort, and efficiency compared to surgical biopsies. CNB uses a hollow needle to extract tissue samples for histological examination, offering a reliable method for detecting malignancies with minimal complications. Its adoption is rapidly increasing, especially in developed and developing countries, where access to advanced diagnostic healthcare is expanding.
The market is also being propelled by significant improvements in imaging guidance technologies such as ultrasound, MRI, and stereotactic systems, which enhance the precision of needle placement and biopsy outcomes. As healthcare systems increasingly emphasize early diagnosis to improve patient outcomes and reduce treatment costs, core needle biopsy is gaining preference over other diagnostic modalities.
Get Free Sample Report@ https://www.snsinsider.com/sample-request/6336
Rising Global Breast Cancer Burden and Government Initiatives Boosting Demand
According to the World Health Organization, breast cancer is the most common cancer among women worldwide, accounting for a significant proportion of cancer diagnoses and deaths. Governments and NGOs are taking proactive steps by launching screening and awareness campaigns, which are expected to fuel the demand for core needle biopsy procedures. Initiatives such as regular mammography screenings and public health policies targeting early diagnosis are creating favorable conditions for market growth.
Furthermore, an increase in research and development investments in oncology diagnostics is anticipated to lead to the development of more sophisticated biopsy tools and kits. The availability of single-use and disposable biopsy needles, which reduce the risk of infection and increase procedural safety, is also contributing to the rise in demand.
Hospitals and Diagnostic Centers Dominate Market Share
In terms of end-users, hospitals and diagnostic imaging centers hold the largest share of the market due to the availability of advanced equipment and specialized healthcare professionals. However, the ambulatory surgical centers segment is expected to witness the highest growth rate in the coming years due to the increasing trend of outpatient diagnostic procedures and reduced healthcare costs.
Regional Insights: North America Leads While Asia-Pacific Emerges as a Lucrative Market
North America currently dominates the Breast Cancer Core Needle Biopsy Market, owing to the region’s well-established healthcare infrastructure, high awareness levels, and strong reimbursement frameworks. Meanwhile, the Asia-Pacific region is expected to register the fastest growth during the forecast period, driven by a large patient base, rising disposable incomes, and government initiatives to improve cancer screening services in countries like China and India.
Key Players in the Market
Several leading companies are actively involved in the development and distribution of core needle biopsy products. Some of the major players include BD (Becton, Dickinson and Company), Hologic Inc., Argon Medical Devices, INRAD Inc., Cook Medical, and others. These players are investing in technological innovation, strategic collaborations, and product launches to strengthen their market positions.
Future Outlook
As the demand for accurate, efficient, and patient-friendly diagnostic tools continues to grow, the Breast Cancer Core Needle Biopsy Market is set to undergo significant transformation. Innovations in biopsy needle design, integration with AI-powered imaging solutions, and wider access to cancer care in developing nations will further shape the future trajectory of this market.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Other Trending Reports
Healthcare Business Intelligence Market Size
Continuous Glucose Monitoring Market Size